Dosage form of L-Methionine S-Sulfoximine

Details Dosage form of L-Methionine S-Sulfoximine Dosage form of L-Methionine S-Sulfoximine

2005-04-05

2005-04-05

Spivack, Phyllis G. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

Reexamination Certificate

active

06875792

ABSTRACT:
Methods for the treatment of both diseases susceptible to the inhibition of mammalian glutamine synthetase and progressive hyperammonemic encephalopathy comprising administering L-methionine S-sulfoxime at a dose not to exceed 10 mg/kg body weight are disclosed. Preferably, the dose should not exceed 8 mg/kg; more preferably, the dose should not exceed 5 mg/kg; most preferably, the dose should not exceed 2.5 mg/kg.

REFERENCES:
Takahashi et al., Circulation Research, 71(5), 1220-1230 (Nov., 1992).*
Harth et al., J. Exp. Med., 189(9), 1425-1435 (May 3, 1999).*
Apostolakis et al., Brain Research Bulletin, vol. 23, pp. 257-262 (1989).*
Ginefri-Gayet et al., Pharmacology Biochemistry and Behavior, vol. 43, pp. 173-179 (1992).*
Blei, Andres T., et al., “Ammonia-Induced Brain Edema and Intracranial Hypertension in Rats After Portacaval Anastomosis,”Hepatology19(6): 1437-1444, Jun. 1994.
Brusilow, Saul W. “Inborn Errors of Urea Synthesis,”In: Scriver CR, Lloyd Jk, eds. Genetic and Metabolic Disease in Pediatrics. 5: 140-165, London: Butterworths, 1985.
Brusilow, Saul W., et al., “Urea Cycle Disorders: Diagnosis, Pathophysiology, and Therapy,”Advances in Pediatrics43:127-170, 1996.
Butterworth, R.F., “Effects of Hyperammonaemia on Brain Function,”J. Inher. Metab. Dis.21(1):6-20, 1998.
Cordoba, Juan, et al., “Brain Edema and Hepatic Encephalopathy,”Seminars in Liver Disease16(3): 271-280, 1996.
Folbergrova, J., “Free Glutamine Level in the Rat Brain In Vivo After Methionine Sulphoximine Administration,”Physiologia Bohemoslovenica13:21-26, 1963.
Gershoff, S.N., et al., “The Relative Effect of Methionine Sulfoximine on Different Animal Species,”J. Nutr. 45:451-458, 1951.
Häussinger, Dieter, et al., “Pathogenesis of Hepatic Encephalopathy,”Journal of Gastroenterology and Hepatology17:S256-S259, 2002.
Hawkins, Richard, et al., “Effect of Reducing Brain Glutamine Synthesis on Metabolic Symptoms of Hepatic Encephalopathy,”Journal of Neurochemistry60(3):1000-1006, 1993.
Hawkins, Richard, et al., “Hyperammonaemia Does Not Impair Brain Function in the Absence of Net Glutamine Synthesis,”Biochem. J. 277:697-703, 1991.
Hirata, Takahiko, et al., “Impaired Pial Arteriolar Reactivity to Hypercapnia During Hyperammonemia Depends on Glutamine Synthesis,”Stroke27(4): 729-736, 1996.
Jonung, Torbjorn, et al., “Methionine Sulfoximine Prevents the Accumulation of Large Neutral Amino Acids in Brain of Hyperammonemic Rats,”J. Surgical Research36:349-353, 1984.
Krakoff, Irwin H., et al., “Effect of Methionine Sulfoximine in Man,”J. Pharm. Experimenetal Ther. 2:599-604, 1961.
Lamar, C., et al., “The Duration of the Inhibition of Glutamine Synthetase by Methionine Sulfoximine,”Biochemical Pharmacology17:636-640, 1968.
Master, Sonali, et al., “Cerebral Blood Flow and the Development of Ammonia-Induced Brain Edema in Rats After Portacaval Anastomosis,”Hepatology30(4): 876-880, 1999.
Norenberg, Michael D., et al.,“Fine Structural Localization of Glutamine Synthetase in Astrocytes of Rat Brain,”Brain Research161:303-310, 1979.
Richman, Paul G., et al., “Inhibition of y-Glutamylcystein Synthetase by L-Methionine-S-Sulfoximine,”J. Biological Chemistry248(19): 6684-6690, 1973.
Rowe, W. Bruce, et al., “Identification of L-Methionine-S-Sulfoximine as the Convulsant Isomer of Methionine Sulfoximine,”Proceedings of the National Academy of Sciences66(2): 500-506, Jun. 1970.
Sellinger, Otto Z., et al., “Methionine Sulfoximine Seizures. VII. the Dissociation of the Convulsant and Glutamine Synthetase Inhibitory Effects,”J. Pharmacology&Experimental Therapeutics161(1): 212-222, 1968.
Sugimoto, Hideyoshi, et al., “Methionine Sulfoximine, A Glutamine Synthetase Inhibitor, Attenuates Increased Extracellular Potassium Activity During Acute Hyperammonemia,”Journal of Cerebral Blood Flow&Metabolism, 17:44-49, 1997.
Takahashi, Hideo, et al., “Inhibition of Brain Glutamine Accumulation Prevents Cerebral Edema in Hyperammonemic Rats,”American Physiological Society261:H825-H829, 1991.
Voorhies, Theresa M., “Acute Hyperammonemia in the Young Primate: Physiologic and Neuropathologic Correlates,”Pediatric Research17(12):970-975, 1983.
Wada, Juhn A., et al., “The Susceptibilty of Auditory Stimuli of Animals Treated with Methionine Sulfoximine,”Experimental Neurology15:157-165, 1966.
Warren, Kenneth S., et al., “Effect of an Inhibitor of Glutamine Synthesis (Methionine Sulfoximine) on Ammonia Toxicity and Metabolism,”J. Lab. &Clin. Med. 64(3): 442-449, 1964.
Watson, Alan J., et al. “Transient Idiopathic Hyperammonaemia in Adults,”The Lancet1271-1274, Dec. 7, 1985.
Willard-Mack, C.L., et al., “Inhibition of Glutamine Synthetase Reduces Ammonia-Induced Astrocyte Swelling in Rat,”Neuroscience71(2): 589-599, 1996.
Zwingmann, Claudia, et al., Multinuclear NMR Spectroscopy Studies on NH4CI-Induced 7Metabolic Alterations and Detoxification Processes in Primary Astrocytes and Glioma Cells,Dev. Neurosci20:417-426, 1998.

Affiliated with

Also associated with

Rating

Dosage form of L-Methionine S-Sulfoximine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dosage form of L-Methionine S-Sulfoximine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage form of L-Methionine S-Sulfoximine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3436260